- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Cancer
Source: Health Policy Watch 23rd July, 2019 WHO has added ten new cancer drugs, including some pricey ones, to its 2019 Essential Medicines List, which provides global guidance to countries and health systems about drugs deemed most essential to patients and … Continue reading
Source: Medicines Law and Policy 24th April, 2019 Picture by James Love. “Medical innovation has little social value if most people cannot access its benefits…. this is a global human rights issue,” said Mariângela Simão, Assistant Director General at … Continue reading
Source: Irish Times 17th April, 2019 Move raises questions of equity between public and private patients VHI will provide wider access to cancer drugs, including Pembrolizumab, for stage three melanoma, and Pertuzumab (Perjeta) for patients with early stage breast cancer. … Continue reading
Source :Health Policy Watch 15th April, 2019 Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use … Continue reading
Source: Irish Times 11th, April 2019 Report says rise could be contained to 50% if recent trends including screening continue Some trends help to lower rates of cancer, such as reduced smoking rates. “There are some grounds for optimism,” says … Continue reading
Source: NEWS18 1st Feb 2019, New Delhi A recent report by the World Health Organisation (WHO) says the standard treatment for breast cancer can drain 10 years of average annual income in India. Forty-five-year old Virendra Sharma’s father was diagnosed … Continue reading
10th Jan 2019, New Delhi Source: Medicines Law and Policy Today, the Dutch Medical Journal (Nederlands Tijdschrift voor Geneeskunde) reported on the case of lutetium-octreotaat, a cancer drug developed by researchers in the Dutch Erasmus medical centre in Rotterdam. For … Continue reading